Astarte Medical

Astarte Medical, founded by Tracy Warren and headquartered in Yardley, Pennsylvania, is a clinical intelligence company focused on improving outcomes for preterm infants and children with medical complexity through data-driven tools.

Reviewed by 7wData
Share Email

On this page

Profile

They provide software tools to help hospitals improve nutrition and care for premature babies in neonatal ICUs.

Astarte Medical, founded by Tracy Warren and headquartered in Yardley, Pennsylvania, is a clinical intelligence company focused on improving outcomes for preterm infants and children with medical complexity through data-driven tools. The company's flagship product, NICUtrition®, is an EMR-integrated clinical decision support platform designed to standardize feeding protocols and optimize nutrition in neonatal ICUs. Astarte raised $7.6 million in a Series A-1 round in September 2021, led by Viking Global Investors and including Lunsford Capital, Ben Franklin Technology Partners, and others.

The funding aimed to scale sales and expand the customer base for NICUtrition. The company has partnered with March of Dimes on the 'Meals That Matter' campaign and joined the NEC Society's community to address necrotizing enterocolitis. Astarte's focus on the first 1,000 days of life—from conception to age two—positions it in a niche but critical segment of pediatric care, where malnutrition and growth disparities in preterm infants remain significant challenges. The company's recent moves suggest a strategic emphasis on partnerships and clinical validation to drive adoption in hospital NICUs.

Track Astarte Medical and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Neonatal intensive care units (NICUs) in hospitals
  • Children's hospitals with complex pediatric care programs
  • Healthcare systems investing in clinical decision support tools
  • Pediatric research institutions studying preterm infant outcomes

Strengths and what to watch

Strengths

  • Specialized focus on preterm infant nutrition, a high-stakes and underserved clinical niche
  • EMR-integrated platform (NICUtrition) designed to reduce variability in NICU feeding protocols
  • Backing from notable investors like Viking Global and Ben Franklin Technology Partners

Watch for

  • Limited disclosed customer traction since 2021 Series A-1 funding round
  • Dependence on hospital budget cycles for NICU technology adoption
  • Competition from broader neonatal care platforms expanding into nutrition analytics

Key Information

Founded
2016
Headquarters
Yardley, Pennsylvania

Frequently Asked Questions

What is Astarte Medical?

Astarte Medical is a clinical intelligence company focused on improving outcomes for preterm infants and children with medical complexity. Their flagship product, NICUtrition®, is an EMR-integrated platform designed to optimize nutrition and standardize feeding protocols in neonatal ICUs.

What does NICUtrition do?

NICUtrition is a clinical decision support platform by Astarte Medical that integrates with electronic medical records (EMRs) to standardize feeding protocols and optimize nutrition for premature babies in neonatal ICUs, addressing malnutrition and growth disparities in preterm infants.

Who uses Astarte Medical's solutions?

Astarte Medical's solutions are used by neonatal ICUs, children's hospitals, healthcare systems investing in clinical decision support, and pediatric research institutions studying preterm infant outcomes. Their focus is on improving nutrition and care for premature babies and children with medical complexity.

What partnerships does Astarte Medical have?

Astarte Medical partners with organizations like March of Dimes for the 'Meals That Matter' campaign and collaborates with the NEC Society to address necrotizing enterocolitis. These partnerships aim to improve neonatal nutrition and care outcomes in hospital NICUs.

How is Astarte Medical funded?

Astarte Medical raised $7.6 million in a Series A-1 funding round in September 2021, led by Viking Global Investors and including Lunsford Capital and Ben Franklin Technology Partners. The funding supports scaling sales and expanding the customer base for NICUtrition.

Why is neonatal nutrition important?

Neonatal nutrition is critical for preterm infants, as malnutrition and growth disparities can lead to long-term health challenges. Astarte Medical's NICUtrition platform helps standardize feeding protocols to optimize nutrition and improve outcomes during the first 1,000 days of life.

Sources

  1. www.prnewswire.com — Series A-1 funding round details and investor list
  2. astartemedical.com — Current product focus and partnership with March of Dimes
  3. astartemedical.com — NICUtrition product description
  4. astartemedical.com — Company's focus on children with medical complexity